Search results for: Marcel A.M. Beijk

Items from 1 to 14 out of 14 results

article

Respiration‐related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration

Rutger G. T. Feenstra, Martijn A. Lavieren, Mauro Echavarria‐Pinto, Gilbert W. Wijntjens, more

Catheterization and Cardiovascular Interventions > 99 > 3 > 844 - 852

Aims We evaluated the occurrence and physiology of respiration‐related beat‐to‐beat variations in resting Pd/Pa and FFR during intravenous adenosine administration, and its impact on clinical decision‐making. Methods and Results Coronary pressure tracings in rest and at plateau hyperemia were analyzed in a total of 39 stenosis from 37 patients, and respiratory rate was calculated with ECG‐derived...

article

Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent

Laura S.M. Kerkmeijer, Jaya Chandrasekhar, Deborah N. Kalkman, Pier Woudstra, more

Catheterization and Cardiovascular Interventions > 98 > 3 > 503 - 510

Objectives This final report from the REMEDEE Registry assessed the long‐term safety and efficacy of the dual‐therapy COMBO stent in a large unselected patient population. Background The bio‐engineered COMBO stent (OrbusNeich Medical BV, The Netherlands) is a dual‐therapy pro‐healing stent. Data of long‐term safety and efficacy of the this stent is lacking. Methods The prospective, multicenter,...

article

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

Ruben Y.G. Tijssen, Rene J. Schaaf, Robin P. Kraak, Maarten A. Vink, more

Catheterization and Cardiovascular Interventions > 95 > 1 > 89 - 96

Background Patients with acute coronary syndrome (ACS) might represent a specific subgroup, in which bioresorbable scaffold implantation in percutaneous coronary intervention (PCI), might lead to better outcomes when compared to conventional treatment with metallic drug eluting stents. In this prespecified subgroup analysis of the Amsterdam Investigator‐Initiated Absorb Strategy All‐Comers (AIDA)...

article

Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome

Deborah N. Kalkman, Pier Woudstra, Huangling Lu, Ian B.A. Menown, more

Catheterization and Cardiovascular Interventions > 90 > 2 > E31 - E37

Background Patients presenting with acute coronary syndrome (ACS) are at increased risk of complications after percutaneous coronary intervention with stent placement compared to patients with stable angina (SA) treated in an elective setting. The novel pro‐healing COMBO stent is a bio‐engineered drug eluting stent designed to promote vessel healing. Therefore, the stent may reduce this difference...

article

Tissue-derived circulating miRNAs can identify atherosclerosis and plaque instability

Maurice De Ronde, Maayke G.M. Kok, Marcel A.M. Beijk, Robbert J. de Winter, more

Atherosclerosis > 2017 > 263 > C > e37

article

Clinical outcomes after bare‐metal stenting in diabetic patients with lesions carrying a low risk of restenosis

Pier Woudstra, Peter Damman, Marcel A.M. Beijk, Maik J.D. Grundeken, more

Catheterization and Cardiovascular Interventions > 81 > 1 > 26 - 33

ObjectiveTo evaluate the clinical results of diabetic patients undergoing percutaneous coronary intervention (PCI) for coronary artery lesions carrying a low risk of restenosis treated with a bare‐metal stent (BMS). BackgroundThere is a discrepancy between current international guidelines on the use of BMS in diabetics with low risk of restenosis coronary artery lesions. Methods and ResultsRegistry...

article

Three‐Year Clinical Follow‐Up of an Unselected Patient Population Treated with the Genous Endothelial Progenitor Cell Capturing Stent

MARGO KLOMP, MARCEL A.M. BEIJK, PETER DAMMAN, PIER WOUDSTRA, more

Journal of Interventional Cardiology > 24 > 5 > 442 - 449

Background: We assessed the 3‐year clinical outcome in our single‐center cohort of mainly unselected patients treated with the endothelial progenitor cell capturing stent (ECS). The ECS is coated with CD34+ antibodies specifically targeting the circulating endothelial progenitor cells population to accelerate endothelialization that in turn may prevent the occurrence of in‐stent restenosis and stent thrombosis (ST)....

article

Two‐year follow‐up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a high‐risk of restenosis

Marcel A.M. Beijk, Margo Klomp, Nan van Geloven, Karel T. Koch, more

Catheterization and Cardiovascular Interventions > 78 > 2 > 189 - 195

Background:In the prospective randomized TRIAS pilot study, the bio‐engineered Genous™ endothelial progenitor cell capturing stent was compared with the Taxus Liberté™ SR paclitaxel‐eluting stent. At 1 yr, a statistically nonsignificant difference in the rates of target vessel failure (cardiac death, myocardial infarction, or target vessel revascularization) was observed. We have evaluated the safety...

article

One‐year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent

Margo Klomp, Marcel A.M. Beijk, Jan G.P. Tijssen, Robbert J. de Winter

Catheterization and Cardiovascular Interventions > 77 > 6 > 809 - 817

Objective: We assessed the 1‐year clinical outcome in a large cohort of unselected patients treated with an endothelial progenitor cell (EPC) capturing coronary stent. Background: The novel EPC capturing stent is coated with CD34+ antibodies that bind circulating EPCs to the stent surface, thereby accelerating endothelialization of the stent struts; it is hypothesized that this may prevent restenosis...

article

Significant intimal hyperplasia regression between 6 and 18months following Genous™ endothelial progenitor cell capturing stent placement

Margo Klomp, Marcel A.M. Beijk, Jan G.P. Tijssen, Robbert J. de Winter

International Journal of Cardiology > 2011 > 147 > 2 > 289-291

article

Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

Peter Damman, Marcel A.M. Beijk, Wichert J. Kuijt, Niels J.W. Verouden, more

Journal of the American College of Cardiology > 2011 > 57 > 1 > 29-36

We investigated whether multiple biomarkers improve prognostication in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.Few data exist on the prognostic value of combined biomarkers.We used data from 1,034 STEMI patients undergoing primary percutaneous coronary intervention in a high-volume percutaneous coronary intervention center in...

article

One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent

Marcel A.M. Beijk, Margo Klomp, Karel T. Koch, José P.S. Henriques, more

Atherosclerosis > 2010 > 213 > 2 > 525-531

Currently no data exists regarding the outcomes after the novel endothelial progenitor cell capturing stent (EPCcS) placement in bifurcation lesions using a provisional T-stenting. This study evaluates the 1-year clinical outcome in patients treated with the EPCcS for a bifurcation lesion using a provisional T-stenting technique and compared these to a historical control group treated with an identical...

article

Long‐term follow‐up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries

Marcel A.M. Beijk, Saskia Z.H. Rittersma, Karel T. Koch, José P.S. Henriques, more

Catheterization and Cardiovascular Interventions > 75 > 7 > 1026 - 1036

Objectives: To evaluate the long‐term outcomes of the selected patients by the local Heart Team to undergo percutaneous coronary intervention (PCI) of unprotected left main coronary artery (ULMCA) stenosis and to compare patients considered at low surgical risk versus at high surgical risk for coronary artery bypass grafting (CABG). Background: CABG is recommended in patients with ULMCA stenosis according...

article

Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program

Margo Klomp, Marcel A.M. Beijk, Niels J.W. Verouden, Jan G.P. Tijssen, more

American Heart Journal > 2009 > 158 > 4 > 527-532.e1

In the treatment of coronary artery disease, a “pro-healing” approach for prevention of in-stent restenosis and late stent thrombosis is intuitively favored over the use of cytotoxic or cytostatic drugs released from a drug-eluting stent (DES). Promoting accelerated endothelial coverage of the stent surface, the endothelial progenitor cell (EPC) capturing stent has shown its safety and efficacy in...

Filter options

Publication date

Last 3 years (1)

Close

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

From:

To:
Set your own date range

Keywords

PERCUTANEOUS CORONARY INTERVENTION (4)
RESTENOSIS (4)
STENT (3)
ENDOTHELIAL PROGENITOR CELL (2)
GENOUS (2)
PCI (2)
STENTS (2)
ACS/NSTEMI (1)
ACUTE CORONARY SYNDROME (1)
BARE‐METAL STENT (1)
BIFURCATION (1)
BIOABSORBABLE DEVICES/POLYMERS (1)
BIOENGINEERED STENT TECHNOLOGY (1)
BIOMARKER (1)
CLINICAL OUTCOMES (1)
CLINICAL RESEARCH (1)
COMBO (1)
CORONARY DISEASE (1)
CORONARY RESTENOSIS (1)
DIABETES COMPLICATIONS (1)
DIABETES MELLITUS (1)
DRUG ELUTING (1)
DRUG‐ELUTING STENT (1)
DUAL‐THERAPY STENT (1)
ENDOTHELIAL PROGENITOR CELL CAPTURING STENT (1)
FRACTIONAL FLOW RESERVE (1)
INTIMAL REGRESSION (1)
PROGNOSTICATION (1)
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (1)
STABLE ANGINA (1)
STENOSIS (1)
STENT THROMBOSIS (1)
TAXUS (1)
UNPROTECTED LEFT MAIN CORONARY ARTERY (1)
more

Data set

Wiley (9)
Elsevier (5)

INFONA - science communication portal

Search results for: Marcel A.M. Beijk

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options